This company listing is no longer active
BNO Overzicht aandelen
A clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers.
Sneeuwvlok Score | |
---|---|
Waardering | 2/6 |
Toekomstige groei | 0/6 |
Prestaties in het verleden | 0/6 |
Financiële gezondheid | 6/6 |
Dividenden | 0/6 |
Bionomics Limited Concurrenten
Prijsgeschiedenis en prestaties
Historische aandelenkoersen | |
---|---|
Huidige aandelenkoers | AU$0.01 |
52 Week Hoogtepunt | AU$0.074 |
52 Week Laag | AU$0.009 |
Bèta | 2.13 |
11 maand verandering | -16.67% |
3 maanden verandering | -52.38% |
1 Jaar Verandering | -81.13% |
33 jaar verandering | -92.86% |
5 jaar verandering | -98.10% |
Verandering sinds IPO | -98.48% |
Recent nieuws en updates
Recent updates
Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Jun 14Is Bionomics (ASX:BNO) In A Good Position To Invest In Growth?
Feb 23Is Bionomics (ASX:BNO) In A Good Position To Deliver On Growth Plans?
Sep 14Companies Like Bionomics (ASX:BNO) Are In A Position To Invest In Growth
Nov 15Did You Miss Bionomics' (ASX:BNO) 86% Share Price Gain?
Dec 30Rendement voor aandeelhouders
BNO | AU Biotechs | AU Markt | |
---|---|---|---|
7D | 0% | -2.6% | -2.0% |
1Y | -81.1% | 28.7% | 20.0% |
Rendement versus industrie: BNO underperformed the Australian Biotechs industry which returned -9.1% over the past year.
Rendement versus markt: BNO underperformed the Australian Market which returned 1.8% over the past year.
Prijsvolatiliteit
BNO volatility | |
---|---|
BNO Average Weekly Movement | 24.4% |
Biotechs Industry Average Movement | 10.4% |
Market Average Movement | 8.7% |
10% most volatile stocks in AU Market | 17.6% |
10% least volatile stocks in AU Market | 3.6% |
Stabiele aandelenkoers: BNO's share price has been volatile over the past 3 months.
Volatiliteit in de loop van de tijd: BNO's weekly volatility has increased from 18% to 24% over the past year.
Over het bedrijf
Opgericht | Werknemers | CEO | Website |
---|---|---|---|
1996 | n/a | Spyros Papapetropoulos | www.bionomics.com.au |
Bionomics Limited Samenvatting
BNO fundamentele statistieken | |
---|---|
Marktkapitalisatie | AU$14.69m |
Inkomsten(TTM) | -AU$24.91m |
Inkomsten(TTM) | AU$6.02m |
2.4x
P/S-verhouding-0.6x
Koers/WinstverhoudingIs BNO overgewaardeerd?
Zie Reële waarde en waarderingsanalyseInkomsten en omzet
BNO resultatenrekening (TTM) | |
---|---|
Inkomsten | AU$6.02m |
Kosten van inkomsten | AU$19.80m |
Brutowinst | -AU$13.79m |
Overige uitgaven | AU$11.13m |
Inkomsten | -AU$24.91m |
Laatst gerapporteerde inkomsten
Dec 31, 2022
Volgende inkomensdatum
n.v.t.
Winst per aandeel (EPS) | -0.017 |
Brutomarge | -229.04% |
Nettowinstmarge | -413.94% |
Schuld/Eigen Vermogen Verhouding | 0% |
Hoe presteerde BNO op de lange termijn?
Bekijk historische prestaties en vergelijking